Bone Density in Adolescents Treated with a GnRH Agonist and Add-Back Therapy for Endometriosis
- 1 October 2007
- journal article
- research article
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 20 (5) , 293-297
- https://doi.org/10.1016/j.jpag.2007.04.008
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- ACOG Committee Opinion #310: Endometriosis in AdolescentsObstetrics & Gynecology, 2005
- Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1Obstetrics & Gynecology, 2002
- Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached?Fertility and Sterility, 1999
- The Effect of Gonadotropin-Releasing Hormone Agonist on Type I Collagen C-Telopeptide and N-Telopeptide: the Predictive Value of Biochemical Markers of Bone TurnoverJournal of Clinical Endocrinology & Metabolism, 1998
- Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month StudyObstetrics & Gynecology, 1998
- Retreatment with nafarelin for recurrent endometriosis symptoms: efficacy, safety, and bone mineral densityFertility and Sterility, 1997
- Urinary N-Telopeptides to Monitor Bone Resorption While on GnRH Agonist TherapyObstetrics & Gynecology, 1996
- Evidence that the loss of bone mass induced by GnRH agonists is not totally recoveredMaturitas, 1995
- Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model.Journal of Clinical Investigation, 1994
- Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trialJournal of Clinical Endocrinology & Metabolism, 1992